Arbutus Biopharma Corp (ABUS)

Jul 09, 2026

Arbutus Biopharma (ABUS) Joins Russell Defensive Indexes And Exits Value Benchmarks - Yahoo! Finance Canada

Jul 09, 2026

Jul 09, 2026

Arbutus Biopharma stock hits 52-week high at 5.34 USD - Investing.com UK

Jul 09, 2026

Jul 09, 2026

Arbutus Biopharma stock hits 52-week high at 5.34 USD By Investing.com - Investing.com Nigeria

Jul 09, 2026

Jul 07, 2026

ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week - Yahoo Finance

Jul 07, 2026

Jul 02, 2026

ABUS Stock Price, Quote & Chart - ChartMill

Jul 02, 2026

Jun 25, 2026

Arbutus Biopharma Corp (ABUS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 25, 2026

Jun 23, 2026

ABUSArbutus Biopharma Corp Options - Finviz

Jun 23, 2026

Jun 22, 2026

Gov't Says It Should Face Vax IP Claims, Not Moderna - Law360

Jun 22, 2026

Jun 21, 2026

Arbutus Biopharma Corp (ABUS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 21, 2026

Jun 17, 2026

Arbutus Biopharma Corp (ABUS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026

Jun 17, 2026

Arbutus Biopharma Corp (ABUS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Arbutus Biopharma Corp (ABUS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 17, 2026

Arbutus Biopharma Corp (ABUS) Institutional Confidence - TradingKey

Jun 17, 2026

Jun 16, 2026

Arbutus Biopharma Corp (ABUS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 16, 2026

Jun 16, 2026

Arbutus Biopharma Corp (ABUS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 16, 2026

Jun 16, 2026

Arbutus Biopharma Corp (ABUS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 16, 2026

Jun 13, 2026

Arbutus Biopharma Corporation (ABUS) Reports Q1 2026 Results - Insider Monkey

Jun 13, 2026

Jun 10, 2026

Arbutus Biopharma (ABUS) director awarded fully vested options on 78,800 shares - Stock Titan

Jun 10, 2026

Jun 10, 2026

Director at Arbutus Biopharma (ABUS) receives 78,800 fully vested stock options - Stock Titan

Jun 10, 2026

Jun 01, 2026

Moderna Tells Fed. Circ. US Must Face COVID Vax Patent Case - Law360

Jun 01, 2026

May 29, 2026

ABUS Technical Analysis | Trend, Signals & Chart Patterns | ARBUTUS BIOPHARMA CORP (NASDAQ:ABUS) - ChartMill

May 29, 2026

May 27, 2026

Shareholders at Arbutus Biopharma (NASDAQ: ABUS) approve 2026 share plan and auditor - Stock Titan

May 27, 2026

May 22, 2026

Arbutus Posts Profit After Moderna Patent Settlement - MyChesCo

May 22, 2026

May 15, 2026

Two Seas (NASDAQ: ABUS) reports 18.56M Arbutus shares; 9.4% stake - Stock Titan

May 15, 2026

May 14, 2026

Arbutus Biopharma Corp Q1 2026 Financial Results and Business Update – Clinical Progress in Hepatitis B Therapies - Minichart

May 14, 2026

May 13, 2026

Arbutus Biopharma Corporation 8-K Filing: Company Details, Financial Data, and NASDAQ Listing (May 2026) - Minichart

May 13, 2026

May 13, 2026

Is Arbutus Biopharma (ABUS) Overvalued After Q1 2026 Earnings Be - GuruFocus

May 13, 2026

May 13, 2026

Arbutus Biopharma (ABUS) Reports Strong Q1 Earnings with $0.87 E - GuruFocus

May 13, 2026

May 13, 2026

Arbutus Biopharma Corp reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2026

May 13, 2026

Arbutus Biopharma earnings beat by $0.91, revenue topped estimates - Investing.com

May 13, 2026

May 13, 2026

Arbutus Biopharma Corp 1Q 2026: Revenue $179.13M, EPS $0.87— 10-Q Summary - TradingView

May 13, 2026

May 13, 2026

Arbutus: Q1 Earnings Snapshot - WKYC

May 13, 2026

May 13, 2026

Moderna settlement drives Arbutus (NASDAQ: ABUS) to $169.7M Q1 profit - Stock Titan

May 13, 2026

May 13, 2026

Arbutus (NASDAQ: ABUS) swings to Q1 profit on $179M revenue surge - Stock Titan

May 13, 2026

May 13, 2026

Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update - Stock Titan

May 13, 2026

May 13, 2026

Arbutus Biopharma: A Fascinating HBV Story, But Still Too Early (NASDAQ:ABUS) - Seeking Alpha

May 13, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 10, 2026

MSN Money - MSN

May 10, 2026

May 08, 2026

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

May 08, 2026

May 06, 2026

Arbutus Biopharma (ABUS) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

May 06, 2026

May 01, 2026

Arbutus Biopharma (ABUS): 10 Best Biotech Penny Stocks to Buy in 2026 - Insider Monkey

May 01, 2026

Apr 30, 2026

5 Best Biotech Penny Stocks to Buy in 2026 - Insider Monkey

Apr 30, 2026

Apr 28, 2026

Whitefort lifts Arbutus (ABUS) economic stake to 9.8% - Stock Titan

Apr 28, 2026

Apr 24, 2026

Arbutus Biopharma (NASDAQ:ABUS) Shares Cross Above 200-Day Moving AverageHere's What Happened - MarketBeat

Apr 24, 2026

Apr 23, 2026

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran - Insider Monkey

Apr 23, 2026

Apr 22, 2026

Arbutus Drug Candidate Receives FDA Fast Track Designation - MyChesCo

Apr 22, 2026